Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera vs Epoetin Beta for Anemia in Dialysis Patients
NCT00442793Phase 3Completed
- Sponsor
- Roche
- Start
- May 2007
- Primary completion
- May 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of methoxy polyethylene glycol-epoetin beta in anemia, sponsored by Roche. Started May 2007; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00442793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442793.